Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Syntheia Signs Definitive Agreement for Call Center Acquisition July 5, 2025 Quimbaya Gold Closes $4 Million Financing and Expands Executive Team July 5, 2025 Lithium Universe LtdInterview with Executive Chairman July 5, 2025